LEXISCAN .08 mg/mL
regadenoson · INJECTION, SOLUTION · Astellas Pharma US, Inc.
No Recall History
Plain English
LEXISCAN is a injection, solution containing regadenoson at .08 mg/mL, taken intravenous. Manufactured by Astellas Pharma US, Inc..
Key Facts
- Brand Name
- LEXISCAN
- Generic Name
- regadenoson
- NDC Code (Product)
0469-6501- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- .08 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA022161
- Drug Class
- Adenosine Receptor Agonist [EPC]
- Marketing Start
- 04/10/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is LEXISCAN used for?
LEXISCAN contains regadenoson. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is LEXISCAN a controlled substance?
LEXISCAN is not classified as a controlled substance by the DEA.
What is the generic name for LEXISCAN?
The generic name for LEXISCAN is regadenoson. There are 11 other brand versions of regadenoson.
What is the NDC code for LEXISCAN .08 mg/mL?
The NDC (National Drug Code) for LEXISCAN .08 mg/mL is 0469-6501, listed by Astellas Pharma US, Inc..